Premiere Date: December 20, 2016
Expiration Date: June 20, 2018
This activity offers CE credits for:
1. Physicians (CME)
To understand the conceptual framework for integrating biomedicine and Asian medicine.
At the end of this CE activity, participants should be able to:
• Discuss the limitations and advantages of biomedicine and Asian medicine
• Assess when it is more beneficial to use biomedicine and when Asian medicine
• Describe the practical guidelines for combining biomedicine and Asian medicine
This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.
CME Credit (Physicians): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC, and Psychiatric Times. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners and Physician Assistants: AANPCP and AAPA accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer-review process.
The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
James Lake, MD, has no disclosures to report.
David Mischoulon, MD (peer/content reviewer), reports that he has received research support from Fisher Wallace, Nordic Naturals, Methylation Sciences Inc, and PharmoRX Therapeutics; he has received honoraria from the Massachusetts General Hospital Psychiatry Academy; and he has received royalties from Lippincott Williams & Wilkins for the book, Natural Medications for Psychiatric Disorders: Considering the Alternatives.
Applicable Psychiatric Times staff and CME Outfitters staff have no disclosures to report.
UNLABELED USE DISCLOSURE
Faculty of this CME/CE activity may include discussion of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, and the faculty do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity?
Call us at 877.CME.PROS (877.263.7767)
Dr. Lake is in private practice in Monterey, CA; he has studied acupuncture and traditional Tibetan medicine, and is the co-author of Chinese Medical Psychiatry: A Textbook and Clinical Manual.
1. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Alt Ther Health Med. 2005;11:42-49.
2. Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression. Cochrane Database Syst Rev. 2004;1:CD003012.
3. Barrett B, Marchand L, Scheder J, et al. Themes of holism, empowerment, access and legitimacy define complementary, alternative and integrative medicine in relation to conventional biomedicine. J Alt Comp Med. 2003;9:936-947.
4. Ohayon M, Lader M. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 2002;63:817-825.
5. Keitner G. Limits to the treatment of major depression. Presented at: American Psychiatric Association Annual Meeting; May 2004; New York, NY.
6. Kligler B, Maizes V, Schachter S, et al. Core competencies in integrative medicine for medical school curricula: a proposal. Acad Med. 2004;79:521-531.
7. Jonas WB, Eisenberg D, Hufford D, Crawford C. The evolution of complementary and alternative medicine (CAM) in the USA over the last 20 years. Forsch Komplementmed. 2013;20:65-72.
8. Astin J, Marie A, Pelletier K, et al. A review of the incorporation of complementary and alternative medicine by mainstream physicians. Arch Intern Med. 1998;158:2303-2310.
9. Kaptchuk T, Eisenberg D. Varieties of healing: medical pluralism in the United States. Ann Intern Med. 2001;135:189-195.
10. Unutzer J, Klap R, Sturm R, et al. Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry. 2000;157:1851-1857.
11. Kessler R, Soukup J, Davis R, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2004;158:289-294.
12. Shorter E, Segesser K. Traditional Chinese medicine and Western psychopharmacology: building bridges. Phytother Res. 2013;27:1739-1744.
13. Lam TP. Strengths and weaknesses of traditional Chinese medicine and Western medicine in the eyes of some Hong Kong Chinese. J Epidemiol Comm Health. 2001;55:762-765.
14. Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande M. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha. Cent Nerv Syst Agents Med Chem. 2010;10:238-246.
15. Millard C. Tibetan medicine and the classification and treatment of mental illness. J Tradit Tibetan Med. 2013;5:8-15.
16. Aung SK, Fay H, Hobbs RF 3rd. Traditional Chinese medicine as a basis for treating psychiatric disorders: a review of theory with illustrative cases. Med Acupunct. 2013;25:398-406.
17. Pratikanti S. Ayurvedic treatments. In: Lake J, Spiegel D, eds. Complementary and Alternative Treatments in Mental Health Care. Arlington, VA: American Psychiatric Publishing; 2007:225-272.
18. Lu A, Jiang M, Zhang C, Chan K. An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. J Ethnopharmacol. 2012;141:549-556.